http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101843573-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2300-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-304 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate | 2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101843573-B1 |
| titleOfInvention | Composition for preventing or treating of Th2-mediated immune disease comprising enzyme-treated extracts from Rosae multiflorae Fructus as an active ingredient |
| abstract | The present invention relates to a composition for preventing or treating a Th2-mediated immune disease, comprising an enzyme-treated spiritual extract as an active ingredient. The composition according to the present invention can maximize the antiallergic effect of the extract of Angelica gigas Nakai, by containing an enzyme-treated spiritual extract as an active ingredient. Specifically, the present inventors and increase considerably the IL-4 produced inhibitory activity as compared to that Youngsil extract to process the result of the enzyme treated with the enzyme treatment Youngsil extract the splenocytes of immune mice with OVA, enzyme treatment in in vivo Youngsil It was confirmed that the serum IgE content of mice immunized with OVA by oral administration of the extract significantly decreased. In addition, since the present invention is advantageous in terms of biocompatibility and stability, the composition according to the present invention can be used as a safe therapeutic agent, a health functional food, a cosmetic, etc. for the prevention, improvement or treatment of Th2- And the like. |
| priorityDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 248.